New technologies in developing recombinant attenuated Salmonella vaccine vectors.

Recombinant attenuated Salmonella vaccine (RASV) vectors producing recombinant gene-encoded protective antigens should have special traits. These features ensure that the vaccines survive stresses encountered in the gastrointestinal tract following oral vaccination to colonize lymphoid tissues without causing disease symptoms and to result in induction of long-lasting protective immune responses. We recently described ways to achieve these goals by using regulated delayed in vivo attenuation and regulated delayed in vivo antigen synthesis, enabling RASVs to efficiently colonize effector lymphoid tissues and to serve as factories to synthesize protective antigens that induce higher protective immune responses. We also developed some additional new strategies to increase vaccine safety and efficiency. Modification of lipid A can reduce the inflammatory responses without compromising the vaccine efficiency. Outer membrane vesicles (OMVs) from Salmonella-containing heterologous protective antigens can be used to increase vaccine efficiency. A dual-plasmid system, possessing Asd+ and DadB+ selection markers, each specifying a different protective antigen, can be used to develop multivalent live vaccines. These new technologies have been adopted to develop a novel, low-cost RASV synthesizing multiple protective pneumococcal protein antigens that could be safe for newborns/infants and induce protective immunity to diverse Streptococcus pneumoniae serotypes after oral immunization.

[1]  I. Charles,et al.  Use of the nirB Promoter to Direct the Stable Expression of Heterologous Antigens in Salmonella Oral Vaccine Strains: Development of a Single–Dose Oral Tetanus Vaccine , 1992, Bio/Technology.

[2]  B. Gunn,et al.  Salmonella Vaccine Vectors Displaying Delayed Antigen Synthesis InVivo To Enhance Immunogenicity , 2010, Infection and Immunity.

[3]  K. Killeen,et al.  Construction and preclinical evaluation of recombinant Peru-15 expressing high levels of the cholera toxin B subunit as a vaccine against enterotoxigenic Escherichia coli. , 2007, Vaccine.

[4]  M. Levine,et al.  Comparison of the safety and immunogenicity of delta aroC delta aroD and delta cya delta crp Salmonella typhi strains in adult volunteers , 1992, Infection and immunity.

[5]  M. Pallen,et al.  Down-Regulation of Key Virulence Factors Makes the Salmonella enterica Serovar Typhimurium rfaH Mutant a Promising Live-Attenuated Vaccine Candidate , 2006, Infection and Immunity.

[6]  K. Gerdes,et al.  The parB (hok/sok) Locus of Plasmid R1: A General Purpose Plasmid Stabilization System , 1988, Bio/Technology.

[7]  M. Inouye,et al.  Regulation of growth and death in Escherichia coli by toxin–antitoxin systems , 2011, Nature Reviews Microbiology.

[8]  S. Miller,et al.  Macrophage-inducible expression of a model antigen in Salmonella typhimurium enhances immunogenicity. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[9]  R. Curtiss,et al.  Stable recombinant avirulent Salmonella vaccine strains. , 1989, Advances in experimental medicine and biology.

[10]  W. Kong,et al.  Protective cellular responses elicited by vaccination with influenza nucleoprotein delivered by a live recombinant attenuated Salmonella vaccine. , 2011, Vaccine.

[11]  Brenda S. Collins,et al.  Gram-negative outer membrane vesicles in vaccine development. , 2011, Discovery medicine.

[12]  B. Gunn,et al.  Salmonella enterica Serovar Typhimurium Strains with Regulated Delayed Attenuation In Vivo , 2008, Infection and Immunity.

[13]  M. Kuehn,et al.  Immunization with Salmonella enterica Serovar Typhimurium-Derived Outer Membrane Vesicles Delivering the Pneumococcal Protein PspA Confers Protection against Challenge with Streptococcus pneumoniae , 2010, Infection and Immunity.

[14]  S. Winfree,et al.  Salmonella – At Home in the Host Cell , 2011, Front. Microbio..

[15]  John Mao,et al.  Phase I study of the intravenous administration of attenuated Salmonella typhimurium to patients with metastatic melanoma. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[16]  T. Aoki,et al.  Outer Membrane Vesicles as a Candidate Vaccine against Edwardsiellosis , 2011, PloS one.

[17]  A. Jansen,et al.  Regulated delayed expression of rfc enhances the immunogenicity and protective efficacy of a heterologous antigen delivered by live attenuated Salmonella enterica vaccines. , 2010, Vaccine.

[18]  S. Boyle,et al.  Characterization of Outer Membrane Vesicles from Brucella melitensis and Protection Induced in Mice , 2011, Clinical & developmental immunology.

[19]  K. Brown,et al.  A naturally derived outer-membrane vesicle vaccine protects against lethal pulmonary Burkholderia pseudomallei infection. , 2011, Vaccine.

[20]  K. Miyake.  Roles for accessory molecules in microbial recognition by Toll-like receptors. , 2006, Journal of endotoxin research.

[21]  M. J. Bailey,et al.  RfaH and the ops element, components of a novel system controlling bacterial transcription elongation , 1997, Molecular microbiology.

[22]  D. Maskell,et al.  Genetic detoxification of an aroA Salmonella enterica serovar Typhimurium vaccine strain does not compromise protection against virulent Salmonella and enhances the immune responses towards a protective malarial antigen. , 2008, FEMS immunology and medical microbiology.

[23]  S. Attridge,et al.  Mutations at rfc or pmi attenuate Salmonella typhimurium virulence for mice , 1991, Infection and immunity.

[24]  H. Pandha,et al.  Novel strains of Salmonella typhimurium as potential vectors for gene delivery. , 2004, FEMS microbiology letters.

[25]  W. Goebel,et al.  Improvement of the live vaccine strain Salmonella enterica serovar Typhi Ty21a for antigen delivery via the hemolysin secretion system of Escherichia coli. , 2009, International journal of medical microbiology : IJMM.

[26]  K. Roland,et al.  PspA Family Fusion Proteins Delivered by Attenuated Salmonella enterica Serovar Typhimurium Extend and Enhance Protection against Streptococcus pneumoniae , 2009, Infection and Immunity.

[27]  W. Kong,et al.  Improving Salmonella vector with rec mutation to stabilize the DNA cargoes , 2011, BMC Microbiology.

[28]  J. Badger,et al.  Identification of novel loci affecting entry of Salmonella enteritidis into eukaryotic cells , 1992, Journal of bacteriology.

[29]  N. Andrews,et al.  Phase I Safety and Immunogenicity Study of a Candidate Meningococcal Disease Vaccine Based on Neisseria lactamica Outer Membrane Vesicles , 2009, Clinical and Vaccine Immunology.

[30]  B. Finlay,et al.  Trafficking of Porin-Deficient Salmonella typhimurium Mutants inside HeLa Cells: ompR andenvZ Mutants Are Defective for the Formation ofSalmonella-Induced Filaments , 1998, Infection and Immunity.

[31]  J. Galán,et al.  Delivery of epitopes by the Salmonella type III secretion system for vaccine development. , 1998, Science.

[32]  D. Mengin-Lecreulx,et al.  Periplasmic phosphorylation of lipid A is linked to the synthesis of undecaprenyl phosphate , 2007, Molecular microbiology.

[33]  M. Hensel,et al.  Salmonella enterica as a vaccine carrier. , 2012, Future microbiology.

[34]  S. Clare,et al.  Salmonella enterica serovar Typhimurium interaction with dendritic cells: impact of the sifA gene , 2004, Cellular microbiology.

[35]  M. Inouye,et al.  NBK/BIK antagonizes MCL-1 and BCL-XL and activates BAK-mediated apoptosis in response to protein synthesis inhibition. , 2007, Genes & development.

[36]  J. Galen,et al.  Salmonella expressing detoxified lipopolysaccharide is immunogenic and protective both as an attenuated vaccine and for delivery of foreign antigens , 2011, Expert review of vaccines.

[37]  S. Bertholet,et al.  New horizons in adjuvants for vaccine development. , 2009, Trends in immunology.

[38]  C. Walsh,et al.  Mutations at the interdomain hinge region of the DadB alanine racemase: effects of length and conformational constraint of the linker sequence on catalytic efficiency. , 1989, Biochemistry.

[39]  P. Dean.  Functional domains and motifs of bacterial type III effector proteins and their roles in infection. , 2011, FEMS microbiology reviews.

[40]  R. Curtiss,et al.  Construction of an ASD+ Expression-Cloning Vector: Stable Maintenance and High Level Expression of Cloned Genes in a Salmonella Vaccine Strain , 1988, Bio/Technology.

[41]  W. Yeh,et al.  LPS/TLR4 signal transduction pathway. , 2008, Cytokine.

[42]  C. Dinarello,et al.  Anticytokine strategies in the treatment of the systemic inflammatory response syndrome. , 1993, JAMA.

[43]  A. Memarnejadian,et al.  Application of outer membrane vesicle of Neisseria meningitidis serogroup B as a new adjuvant to induce strongly Th1-oriented responses against HIV-1. , 2011, Current HIV research.

[44]  Wei Kong,et al.  Regulated programmed lysis of recombinant Salmonella in host tissues to release protective antigens and confer biological containment , 2008, Proceedings of the National Academy of Sciences.

[45]  R. Curtiss,et al.  Oral and rectal immunization of adult female volunteers with a recombinant attenuated Salmonella typhi vaccine strain , 1996, Infection and immunity.

[46]  T. Kirikae,et al.  Bacterial endotoxin: molecular relationships of structure to activity and function , 1994, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[47]  R. Germanier,et al.  Isolation and characterization of Gal E mutant Ty 21a of Salmonella typhi: a candidate strain for a live, oral typhoid vaccine. , 1975, The Journal of infectious diseases.

[48]  S. Porwollik,et al.  Humanized nonobese diabetic-scid IL2rγnull mice are susceptible to lethal Salmonella Typhi infection , 2010, Proceedings of the National Academy of Sciences.

[49]  D. Gibbons,et al.  Mouse and human intestinal immunity: same ballpark, different players; different rules, same score , 2011, Mucosal Immunology.

[50]  P. A. van der Ley,et al.  Outer membrane vesicles obtained from Bordetella pertussis Tohama expressing the lipid A deacylase PagL as a novel acellular vaccine candidate. , 2011, Vaccine.

[51]  I. Feavers,et al.  Adjuvant properties of meningococcal outer membrane vesicles and the use of adjuvants in Neisseria meningitidis protein vaccines , 2011, Expert review of vaccines.

[52]  S. McSorley,et al.  Activation of Salmonella-specific immune responses in the intestinal mucosa , 2006, Archivum Immunologiae et Therapiae Experimentalis.

[53]  J. Hacker,et al.  Oral Immunization with an rfaH Mutant Elicits Protection against Salmonellosis in Mice , 2004, Infection and Immunity.

[54]  T. Cherian,et al.  Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates , 2009, The Lancet.

[55]  Xiaoyuan Wang,et al.  MsbA Transporter-dependent Lipid A 1-Dephosphorylation on the Periplasmic Surface of the Inner Membrane , 2004, Journal of Biological Chemistry.

[56]  R. Curtiss,et al.  Salmonella typhimurium deletion mutants lacking adenylate cyclase and cyclic AMP receptor protein are avirulent and immunogenic , 1987, Infection and immunity.

[57]  B. Gunn,et al.  Induction of Host Immune Responses Using Salmonella-Vectored Vaccines , 2007 .

[58]  C. Hughes,et al.  Of Mice and Not Men: Differences between Mouse and Human Immunology , 2004, The Journal of Immunology.

[59]  L. Collins,et al.  Molecular cloning, characterization, and nucleotide sequence of the rfc gene, which encodes an O-antigen polymerase of Salmonella typhimurium , 1991, Journal of bacteriology.

[60]  R. Curtiss.  Bacterial infectious disease control by vaccine development. , 2002, The Journal of clinical investigation.

[61]  M. Inouye,et al.  Insights into the mRNA Cleavage Mechanism by MazF, an mRNA Interferase* , 2005, Journal of Biological Chemistry.

[62]  J. Hacker,et al.  Loss of Regulatory Protein RfaH Attenuates Virulence of Uropathogenic Escherichia coli , 2002, Infection and Immunity.

[63]  B. Gunn,et al.  A sopB Deletion Mutation Enhances the Immunogenicity and Protective Efficacy of a Heterologous Antigen Delivered by Live Attenuated Salmonella enterica Vaccines , 2008, Infection and Immunity.

[64]  S. Akira,et al.  TRAM couples endocytosis of Toll-like receptor 4 to the induction of interferon-β , 2008, Nature Immunology.

[65]  M. Wick,et al.  Early cellular responses to Salmonella infection: dendritic cells, monocytes, and more , 2008, Immunological reviews.

[66]  B. Stocker,et al.  Vaccination of calves against Salmonella dublin with aromatic-dependent Salmonella typhimurium. , 1984, American journal of veterinary research.

[67]  Samuel I. Miller,et al.  Lipid A mutant Salmonella with suppressed virulence and TNFα induction retain tumor-targeting in vivo , 1999, Nature Biotechnology.

[68]  M. F. Edwards,et al.  Safety, infectivity, immunogenicity, and in vivo stability of two attenuated auxotrophic mutant strains of Salmonella typhi, 541Ty and 543Ty, as live oral vaccines in humans. , 1987, The Journal of clinical investigation.

[69]  Samuel I. Miller,et al.  LPS, TLR4 and infectious disease diversity , 2005, Nature Reviews Microbiology.

[70]  C. Haidaris,et al.  Mutants of Salmonella typhimurium that cannot survive within the macrophage are avirulent. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[71]  J. Irache,et al.  Mucosal immunization with Shigella flexneri outer membrane vesicles induced protection in mice. , 2011, Vaccine.

[72]  D. R. Leitner,et al.  Intranasal Immunization with Nontypeable Haemophilus influenzae Outer Membrane Vesicles Induces Cross-Protective Immunity in Mice , 2012, PloS one.

[73]  Elizabeth A. Warner,et al.  Construction and screening of attenuated ΔphoP/Q Salmonella typhimurium vectored plague vaccine candidates , 2012, Human vaccines & immunotherapeutics.

[74]  Qing Liu,et al.  Regulated Delayed Expression of rfaH in an Attenuated Salmonellaenterica Serovar Typhimurium Vaccine Enhances Immunogenicity of Outer Membrane Proteins and a Heterologous Antigen , 2009, Infection and Immunity.

[75]  E. Rietschel,et al.  Lipid A antiserum-mediated protection against lipopolysaccharide- and lipid A-induced fever and skin necrosis , 1977, Infection and immunity.

[76]  S. Akira,et al.  Protection from lethal Gram-negative bacterial sepsis by targeting Toll-like receptor 4 , 2009, Proceedings of the National Academy of Sciences.

[77]  G. Dougan,et al.  Use of the stationary phase inducible promoters, spv and dps, to drive heterologous antigen expression in Salmonella vaccine strains. , 2000, Vaccine.

[78]  M. Levine,et al.  Salmonella enterica serovar Typhi live vector vaccines finally come of age , 2009, Immunology and cell biology.

[79]  D. Kopecko,et al.  Genetic stability of vaccine strain Salmonella Typhi Ty21a over 25 years. , 2009, International journal of medical microbiology : IJMM.

[80]  B. McCormick,et al.  Salmonella effectors: important players modulating host cell function during infection , 2011, Cellular microbiology.

[81]  K. I. Sørensen,et al.  A Food-Grade Cloning System for Industrial Strains of Lactococcus lactis , 2000, Applied and Environmental Microbiology.

[82]  H. Engelberg-Kulka,et al.  An Escherichia coli chromosomal "addiction module" regulated by guanosine [corrected] 3',5'-bispyrophosphate: a model for programmed bacterial cell death. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[83]  M. Moreno,et al.  Salmonella as live trojan horse for vaccine development and cancer gene therapy. , 2010, Current gene therapy.

[84]  J. Santander,et al.  The Asd+-DadB+ Dual-Plasmid System Offers a Novel Means To Deliver Multiple Protective Antigens by a Recombinant Attenuated Salmonella Vaccine , 2012, Infection and Immunity.

[85]  T. Kirikae,et al.  The chemical structure of bacterial endotoxin in relation to bioactivity. , 1993, Immunobiology.

[86]  M. Evans,et al.  Effect of antibiotic class and concentration on the release of lipopolysaccharide from Escherichia coli. , 1993, The Journal of infectious diseases.

[87]  R. Curtiss,et al.  Immune responses dependent on antigen location in recombinant attenuated Salmonella typhimurium vaccines following oral immunization. , 2003, FEMS immunology and medical microbiology.

[88]  G. Dougan,et al.  Identification and characterization of TnphoA mutants of Salmonella that are unable to pass through a polarized MDCK epithelial cell monolayer , 1988, Molecular microbiology.

[89]  A. Cohen,et al.  Plasmidic recombination in Escherichia coliK-12: The role of recF gene function , 2004, Molecular and General Genetics MGG.

[90]  G. Dougan,et al.  Oral vaccination of calves against experimental salmonellosis using a double aro mutant of Salmonella typhimurium. , 1991, Vaccine.

[91]  A. Ashkar,et al.  Humanized mice are susceptible to Salmonella typhi infection , 2011, Cellular and Molecular Immunology.

[92]  Xiaoyuan Wang,et al.  Salmonella Synthesizing 1-Monophosphorylated Lipopolysaccharide Exhibits Low Endotoxic Activity while Retaining Its Immunogenicity , 2011, The Journal of Immunology.

[93]  A. Pekosz,et al.  Delivery of woodchuck hepatitis virus-like particle presented influenza M2e by recombinant attenuated Salmonella displaying a delayed lysis phenotype. , 2010, Vaccine.

[94]  C. Raetz,et al.  Phosphate Groups of Lipid A Are Essential for Salmonella enterica Serovar Typhimurium Virulence and Affect Innate and Adaptive Immunity , 2012, Infection and Immunity.

[95]  J. Galán,et al.  Induction of specific CD8+ memory T cells and long lasting protection following immunization with Salmonella typhimurium expressing a lymphocytic choriomeningitis MHC class I-restricted epitope. , 2001, Vaccine.

[96]  Qing Liu,et al.  Effect of Deletion of Genes Involved in Lipopolysaccharide Core and O-Antigen Synthesis on Virulence and Immunogenicity of Salmonella enterica Serovar Typhimurium , 2011, Infection and Immunity.

[97]  R. Kolodner,et al.  Genetic recombination of bacterial plasmid DNA: effect of RecF pathway mutations on plasmid recombination in Escherichia coli , 1985, Journal of bacteriology.

[98]  M. Schmidt,et al.  Development of a tripartite vector system for live oral immunization using a gram-negative probiotic carrier. , 2008, International journal of medical microbiology : IJMM.

[99]  H. Smith,et al.  The use of live vaccines in experimental Salmonella gallinarum infection in chickens with observations on their interference effect , 1956, Journal of Hygiene.

[100]  J. Roth,et al.  Virulence Mechanisms of Bacterial Pathogens , 1995 .

[101]  E. Fuerer,et al.  Immunity in Experimental Salmonellosis II. Basis for the Avirulence and Protective Capacity of gal E Mutants of Salmonella typhimurium , 1971, Infection and immunity.

[102]  R. B. Jensen,et al.  Programmed cell death in bacteria: proteic plasmid stabilization systems , 1995, Molecular microbiology.

[103]  G. Geginat,et al.  Protection Against Murine Listeriosis by Oral Vaccination with Recombinant Salmonella Expressing Hybrid Yersinia Type III Proteins1 , 2001, The Journal of Immunology.

[104]  M. Levine,et al.  A New Generation of Stable, Nonantibiotic, Low-Copy-Number Plasmids Improves Immune Responses to Foreign Antigens in Salmonella enterica Serovar Typhi Live Vectors , 2009, Infection and Immunity.

[105]  C. Raetz,et al.  Lipid A modification systems in gram-negative bacteria. , 2007, Annual review of biochemistry.

[106]  C. Raetz,et al.  Palmitoylation State Impacts Induction of Innate and Acquired Immunity by the Salmonella enterica Serovar Typhimurium msbB Mutant , 2011, Infection and Immunity.

[107]  D. Monack,et al.  Innate immune response to Salmonella typhimurium, a model enteric pathogen , 2012, Gut microbes.

[108]  K. Gerdes,et al.  Toxin-antitoxin loci as stress-response-elements: ChpAK/MazF and ChpBK cleave translated RNAs and are counteracted by tmRNA. , 2003, Journal of molecular biology.

[109]  T. Hughes,et al.  Identification of a Bacterial Type III Effector Family with G Protein Mimicry Functions , 2006, Cell.

[110]  T. Ebensen,et al.  An SopB-mediated immune escape mechanism of Salmonella enterica can be subverted to optimize the performance of live attenuated vaccine carrier strains. , 2006, Microbes and infection.

[111]  D. Belin,et al.  Tight regulation, modulation, and high-level expression by vectors containing the arabinose PBAD promoter , 1995, Journal of bacteriology.

[112]  P. Ley,et al.  Next-generation outer membrane vesicle vaccines against Neisseria meningitidis based on nontoxic LPS mutants , 2011 .

[113]  R. Curtiss,et al.  Analysis of Type II Secretion of Recombinant Pneumococcal PspA and PspC in a Salmonella enterica Serovar Typhimurium Vaccine with Regulated Delayed Antigen Synthesis , 2008, Infection and Immunity.

[114]  M. Levine,et al.  Optimization of Plasmid Maintenance in the Attenuated Live Vector Vaccine Strain Salmonella typhiCVD 908-htrA , 1999, Infection and Immunity.

[115]  C. Hellerqvist,et al.  Rough mutants of Salmonella typhimurium: immunochemical and structural analysis of lipopolysaccharides from rfaH mutants. , 1980, Journal of general microbiology.

[116]  M. Levine,et al.  Adaptation of the Endogenous Salmonella enterica Serovar Typhi clyA-Encoded Hemolysin for Antigen Export Enhances the Immunogenicity of Anthrax Protective Antigen Domain 4 Expressed by the Attenuated Live-Vector Vaccine Strain CVD 908-htrA , 2004, Infection and Immunity.

[117]  X. Luo,et al.  Antitumor effect of VNP20009, an attenuated Salmonella, in murine tumor models. , 2001, Oncology research.

[118]  MJ Mahan,et al.  Selection of bacterial virulence genes that are specifically induced in host tissues , 1993, Science.

[119]  D. Rowley.  Sensitivity of Rough Gram-negative Bacteria to the Bactericidal Action of Serum , 1968, Journal of bacteriology.

[120]  Thomas C. Mitchell,et al.  The Vaccine Adjuvant Monophosphoryl Lipid A as a TRIF-Biased Agonist of TLR4 , 2007, Science.

[121]  K. Brown,et al.  Salmonella vaccines for use in humans: present and future perspectives. , 2002, FEMS microbiology reviews.

[122]  R. Alaniz,et al.  Membrane Vesicles Are Immunogenic Facsimiles of Salmonella typhimurium That Potently Activate Dendritic Cells, Prime B and T Cell Responses, and Stimulate Protective Immunity In Vivo1 , 2007, The Journal of Immunology.

[123]  Andreas Tauch,et al.  The alanine racemase gene alr is an alternative to antibiotic resistance genes in cloning systems for industrial Corynebacterium glutamicum strains. , 2002, Journal of biotechnology.

[124]  R. Curtiss,et al.  Selective delivery of antigens by recombinant bacteria. , 1989, Current topics in microbiology and immunology.

[125]  Wei Sun,et al.  Comparison of a Regulated Delayed Antigen Synthesis System with In Vivo-Inducible Promoters for Antigen Delivery by Live Attenuated Salmonella Vaccines , 2010, Infection and Immunity.

[126]  K. Roland,et al.  Immune Responses to Recombinant Pneumococcal PsaA Antigen Delivered by a Live Attenuated Salmonella Vaccine , 2010, Infection and Immunity.

[127]  B. Finlay,et al.  Salmonella interactions with host cells: in vitro to in vivo. , 2000, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.

[128]  Haruo Watanabe,et al.  Outer Membrane Vesicles of Porphyromonas gingivalis Elicit a Mucosal Immune Response , 2011, PloS one.

[129]  M. Inouye,et al.  Toxin-antitoxin systems in bacteria and archaea. , 2011, Annual review of genetics.

[130]  B. Gunn,et al.  Evaluation of new generation Salmonella enterica serovar Typhimurium vaccines with regulated delayed attenuation to induce immune responses against PspA , 2009, Proceedings of the National Academy of Sciences.

[131]  D. Morrison,et al.  Structure-function relationships of bacterial endotoxins. Contribution to microbial sepsis. , 1999, Infectious disease clinics of North America.

[132]  Xiao-lian Zhang,et al.  Salmonella Typhi: from a Human Pathogen to a Vaccine Vector , 2008, Cellular and Molecular Immunology.

[133]  S. Miller,et al.  Evaluation of a phoP/phoQ-deleted, aroA-deleted live oral Salmonella typhi vaccine strain in human volunteers. , 1996, Vaccine.

[134]  D. Botstein,et al.  Two alanine racemase genes in Salmonella typhimurium that differ in structure and function , 1983, Journal of bacteriology.

[135]  M. Hovi,et al.  Protective immunity in mouse salmonellosis: comparison of smooth and rough live and killed vaccines. , 1989, Microbial pathogenesis.

[136]  B. Finlay,et al.  Salmonella induces the formation of filamentous structures containing lysosomal membrane glycoproteins in epithelial cells. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[137]  S. Attridge,et al.  A galE via (Vi antigen-negative) mutant of Salmonella typhi Ty2 retains virulence in humans , 1988, Infection and immunity.

[138]  B. Stocker,et al.  Aromatic-dependent Salmonella typhimurium as modified live vaccines for calves. , 1984, American journal of veterinary research.

[139]  B. Gunn,et al.  Presence of Wild-Type and Attenuated Salmonella enterica Strains in Brain Tissues following Inoculation of Mice by Different Routes , 2008, Infection and Immunity.

[140]  A. Ashkar,et al.  Humanized mice for Salmonella typhi infection: new tools for an old problem , 2011, Virulence.

[141]  D. Botstein,et al.  Biosynthetic alr alanine racemase from Salmonella typhimurium: DNA and protein sequence determination. , 1986, Biochemistry.

[142]  Shizuo Akira,et al.  TLR signaling pathways. , 2004, Seminars in immunology.

[143]  S. Cryz,et al.  Phase I clinical trials of aroA aroD and aroA aroD htrA attenuated S. typhi vaccines; effect of formulation on safety and immunogenicity. , 2000, Vaccine.

[144]  A. Gorringe,et al.  Induction of immune responses by purified outer membrane protein complexes from Neisseria meningitidis. , 2012, Vaccine.

[145]  S. Marathe,et al.  Typhoid fever & vaccine development: a partially answered question , 2012, The Indian journal of medical research.

[146]  E. Fuerer,et al.  Characteristics of the attenuated oral vaccine strain "S. typhi" Ty 21a. , 1983, Developments in biological standardization.

[147]  Zhimin Zhou,et al.  Function of the Escherichia coli msbB Gene, a Multicopy Suppressor of htrB Knockouts, in the Acylation of Lipid A , 1997, The Journal of Biological Chemistry.

[148]  J. Moon,et al.  Tracking the dynamics of salmonella specific T cell responses. , 2009, Current topics in microbiology and immunology.

[149]  B. Gunn,et al.  New technologies in using recombinant attenuated Salmonella vaccine vectors. , 2010, Critical reviews in immunology.

[150]  P. Reeves.  Role of O-antigen variation in the immune response. , 1995, Trends in microbiology.

[151]  D. Maskell,et al.  Recent advances in the field of Salmonella Typhi vaccines , 2010, Human vaccines.

[152]  S. Akira,et al.  Pattern Recognition Receptors and Inflammation , 2010, Cell.

[153]  L. Isaksson,et al.  A host/plasmid system that is not dependent on antibiotics and antibiotic resistance genes for stable plasmid maintenance in Escherichia coli. , 2004, Journal of biotechnology.

[154]  R. Curtiss,et al.  Recombinant Attenuated Salmonella enterica Serovar Typhimurium Expressing the Carboxy-Terminal Domain of Alpha Toxin from Clostridium perfringens Induces Protective Responses against Necrotic Enteritis in Chickens , 2008, Clinical and Vaccine Immunology.

[155]  Wei Sun,et al.  Live Recombinant Salmonella Typhi Vaccines Constructed to Investigate the Role of rpoS in Eliciting Immunity to a Heterologous Antigen , 2010, PloS one.

[156]  V. Morozov,et al.  Proteomic characterization and functional analysis of outer membrane vesicles of Francisella novicida suggests possible role in virulence and use as a vaccine. , 2011, Journal of proteome research.

[157]  A. Camilli,et al.  Immunization of Mice With Vibrio cholerae Outer-Membrane Vesicles Protects Against Hyperinfectious Challenge and Blocks Transmission , 2011, The Journal of infectious diseases.

[158]  Gaëlle Vandermeulen,et al.  New generation of plasmid backbones devoid of antibiotic resistance marker for gene therapy trials. , 2011, Molecular therapy : the journal of the American Society of Gene Therapy.

[159]  J. Galán,et al.  Cloning and characterization of the asd gene of Salmonella typhimurium: use in stable maintenance of recombinant plasmids in Salmonella vaccine strains. , 1990, Gene.

[160]  A. Camilli,et al.  Mucosal Immunization with Vibrio cholerae Outer Membrane Vesicles Provides Maternal Protection Mediated by Antilipopolysaccharide Antibodies That Inhibit Bacterial Motility , 2010, Infection and Immunity.

[161]  D. Putnam,et al.  Delivery of foreign antigens by engineered outer membrane vesicle vaccines , 2010, Proceedings of the National Academy of Sciences.

[162]  J. Pugin,et al.  Contribution of Toll-like receptors to the innate immune response to Gram-negative and Gram-positive bacteria. , 2007, Blood.

[163]  K. Killeen,et al.  Development of a ΔglnA Balanced Lethal Plasmid System for Expression of Heterologous Antigens by Attenuated Vaccine Vector Strains of Vibrio cholerae , 2000, Infection and Immunity.

[164]  P. Dull,et al.  Meningococcal vaccine development--from glycoconjugates against MenACWY to proteins against MenB--potential for broad protection against meningococcal disease. , 2012, Vaccine.

[165]  M. Levine,et al.  Mouse models to assess the efficacy of non-typhoidal Salmonella vaccines: revisiting the role of host innate susceptibility and routes of challenge. , 2011, Vaccine.

[166]  Hayyoung Lee,et al.  The structural basis of lipopolysaccharide recognition by the TLR4–MD-2 complex , 2009, Nature.

[167]  K. Jeong,et al.  Multi-immunogenic outer membrane vesicles derived from an MsbB-deficient Salmonella enterica serovar typhimurium mutant. , 2009, Journal of microbiology and biotechnology.

[168]  R. Curtiss,et al.  Immune Responses to Recombinant Pneumococcal PspA Antigen Delivered by Live Attenuated Salmonella enterica Serovar Typhimurium Vaccine , 2002, Infection and Immunity.

[169]  R. Curtiss,et al.  Immunology and Immunopathology of the Intestines: Recombinant Avirulent Salmonella Vaccine Strains with Stable Maintenance and High Level Expression of Cloned Genes in Vivo , 1989 .

[170]  A. Dofferhoff,et al.  Effects of different types and combinations of antimicrobial agents on endotoxin release from gram-negative bacteria: an in-vitro and in-vivo study. , 1991, Scandinavian journal of infectious diseases.

[171]  S. McSorley,et al.  Development of protective immunity to Salmonella, a mucosal pathogen with a systemic agenda , 2011, Mucosal Immunology.

[172]  P. Maciag,et al.  Live, attenuated strains of Listeria and Salmonella as vaccine vectors in cancer treatment , 2010, Bioengineered bugs.

[173]  F. O'Gara,et al.  Thymidylate synthase gene from Lactococcus lactis as a genetic marker: an alternative to antibiotic resistance genes , 1990, Applied and environmental microbiology.

[174]  R. Flavell,et al.  A mouse model for the human pathogen Salmonella typhi. , 2010, Cell host & microbe.

[175]  M. Inouye,et al.  Single protein production (SPP) system in Escherichia coli , 2007, Nature Protocols.

[176]  A. Kalergis,et al.  Evasion of host immunity by virulent Salmonella: implications for vaccine design. , 2011, Current medicinal chemistry.

[177]  W. Goebel,et al.  The E. coli α-hemolysin secretion system and its use in vaccine development , 2002 .

[178]  T. Merkel,et al.  Anthrax Protective Antigen Delivered by Salmonella enterica Serovar Typhi Ty21a Protects Mice from a Lethal Anthrax Spore Challenge , 2009, Infection and Immunity.

[179]  L. Wood,et al.  Listeria and Salmonella bacterial vectors of tumor-associated antigens for cancer immunotherapy. , 2010, Seminars in immunology.

[180]  A. Chopra,et al.  An Enteric Pathogen Salmonella enterica serovar Typhimurium Suppresses Tumor Growth by Down Regulating CD44high and CD4 T Regulatory (Treg) Cell Expression in Mice: Critical Role of Lipopolysaccharide and Braun Lipoprotein in Modulating Tumor Growth , 2009, Cancer Gene Therapy.

[181]  A. Lindberg,et al.  Salmonella choleraesuis strains deficient in O antigen remain fully virulent for mice by parenteral inoculation but are avirulent by oral administration , 1990, Infection and immunity.

[182]  W. Goebel,et al.  Listeria monocytogenes as novel carrier system for the development of live vaccines. , 2008, International journal of medical microbiology : IJMM.

[183]  R. Curtiss,et al.  Isolation and characterization of a gene involved in hemagglutination by an avian pathogenic Escherichia coli strain , 1994, Infection and immunity.

[184]  R. Bone,et al.  Toward an epidemiology and natural history of SIRS (systemic inflammatory response syndrome) , 1992, JAMA.

[185]  M. Inouye,et al.  Single protein production in living cells facilitated by an mRNA interferase. , 2005, Molecular cell.

[186]  C. Walsh,et al.  Inactivation of the dadB Salmonella typhimurium alanine racemase by D and L isomers of beta-substituted alanines: kinetics, stoichiometry, active site peptide sequencing, and reaction mechanism. , 1984, Biochemistry.